New syphilis test provides quicker and easier diagnosis
Newmarket Laboratories, part of the Lab21 Group has developed a new diagnostic test for syphilis which is rapid, accurate and easy to use, according to the company. The new syphilis IgM antibody test uses recombinant antigens, which have a high level of sensitivity, and reduce the risk of false positive results. In addition the test can be performed in as little as two hours.
The assay's primary function is to detect IgM antibodies which are particularly useful for detection of primary infections but can also be used in differential diagnosis of syphilis pathology.
Most read news
Organizations
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Researchers successfully test device that analyzes components within a vacuum
Study finds potential new biomarker for cancer patient prognosis
The "profile" of neon becomes more exact - PTB researchers determine the polarizability of neon with extreme accuracy - their procedure helps to revise theoretical models and is also of use for other elements
Domestic cat genome sequenced
SPECTRO Reaches Milestone with Shipment of 40,000th Instrument
Cells bulge to squeeze through barriers
Johnson & Johnson Nordic AB Acquires Amic - Gains Access to In Vitro Diagnostic Technologies in Development for Use in Point-of-Care Settings
ATLAS Biolabs fulfills the DIN EN ISO 13485:2003 + AC: 2009 standard for designing and manufacturing medical devices
Right under your nose: A more convenient way to diagnose Alzheimer's disease - Certain proteins in nasal discharge can indicate the onset and progression of Alzheimer's, providing an avenue for early detection
Wiley InterScience Launches the Analytical Sciences Backfile Collection
A swallowable test to detect pre-cancerous Barrett's esophagus